Integrative omics reveals MYCN as a global suppressor of cellular signalling and enables network-based therapeutic target discovery in neuroblastoma.
Duffy DJ, Krstic A, Halasz M, Schwarzl T, Fey D, Iljin K, Mehta JP, Killick K, Whilde J, Turriziani B, Haapa-Paananen S, Fey V, Fischer M, Westermann F, Henrich KO, Bannert S, Higgins DG, Kolch W.
Duffy DJ, et al. Among authors: kolch w.
Oncotarget. 2015 Dec 22;6(41):43182-201. doi: 10.18632/oncotarget.6568.
Oncotarget. 2015.
PMID: 26673823
Free PMC article.